HKD 11.24
(1.81%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 14.75 Million CNY | 52.67% |
2022 | 9.66 Million CNY | -54.74% |
2021 | 21.34 Million CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 22.45 Million CNY | 0.0% |
2024 Q1 | 22.45 Million CNY | 131.16% |
2023 Q4 | 9.71 Million CNY | 0.0% |
2023 Q3 | - CNY | 0.0% |
2023 FY | 14.75 Million CNY | 52.67% |
2023 Q2 | - CNY | 0.0% |
2023 Q1 | - CNY | -100.0% |
2022 FY | 9.66 Million CNY | -54.74% |
2022 Q4 | 7.6 Million CNY | 0.0% |
2021 FY | 21.34 Million CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Uni-Bio Science Group Limited | 484.71 Million HKD | 96.957% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.32 Billion HKD | 99.723% |